Replies to post #817844 on NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

NWBO Form 8-K, Filed Jan 15, 2026 | Item 8.01: Other Events
"Under the terms of the Settlement Agreement, the Company's insurance carriers will pay $2.25 million to the Company, 17% of the challenged 2020 options will be cancelled, and the parties will fully, finally, and forever resolve, discharge, and settle claims against each other..."
The Scheduled Hammer:
"The Settlement Agreement and any award of fees and expenses are subject to approval by the Court at a hearing scheduled for 1:30 pm ET on March 16, 2026, at the Leonard L. Williams Justice Center in Wilmington, Delaware."
THE DEBUNKING: FOR THE "2-YEAR-OLD BRAIN"
Claim: "The settlement is just something [User] is claiming."
Fact: It is a Binding Stipulation and Agreement of Compromise signed by Linda Powers on behalf of Northwest Biotherapeutics, Inc..
Claim: "The court isn't canceling options tomorrow."
Fact: The hearing tomorrow at 1:30 PM ET is the final legal trigger for the 17% cancellation. This is not a "discussion"—it is a court-mandated deletion of supply.
Claim: "This doesn't affect the market."
Fact: As I've established, these 2020 grants have served as "Locates" for synthetic short positions. When 17% of that pool is deleted by the Delaware Court of Chancery, the MMs lose their legal cover